Ossman Rime, Buob David, Hellmark Thomas, Brocheriou Isabelle, Peltier Julie, Tamouza Ryad, Dahan Karine, Hertig Alexandre, Rondeau Eric, Galichon Pierre
From the Urgences Néphrologiques et Transplantation Rénale (RO, JP, AH, ER, PG); Service d'Anatomie Pathologique (DB, IB); Service de Néphrologie et Dialyses (KD), Hôpital Tenon; Université Pierre et Marie Curie (DB, IB, AH, ER, PG), (Paris 6), Sorbonne Universités, Paris, France; Department of Nephrology (TH), Clinical Sciences in Lund, Lund University, Lund, Sweden; and Laboratoire Jean Dausset (LabEX Transplantex) et Inserm UMRS 1160 (RT), Hôpital Saint Louis, Paris, France.
Medicine (Baltimore). 2016 May;95(19):e3654. doi: 10.1097/MD.0000000000003654.
Antiglomerular basement membrane (GBM) disease is known as a super-acute proliferative glomerulonephritis caused by auto-antibodies targeting the NC1 domain of the α3 chain of type IV collagen.Here, we describe a case of atypical anti-GBM disease presenting as a dialysis-dependent acute renal failure with unusual mild glomerular involvement. We found that immunoglobulin G (IgG) deposits were restricted to the uncommon IgG2 and IgG4 subclasses, and that blood was positive for anti-GBM antibodies by immunofluorescence, but not by Enzyme Linked Immunosorbent Assay (ELISA). The patient was treated with plasma exchanges, corticosteroids, and cyclosphosphamide. He eventually regained a normal renal function.This case demonstrates that biopsy-proven anti-GBM disease can have reduced pathogenicity. Referring to previous studies of anti-GBM detection in the blood from healthy or minimally ill individuals, we discuss the antigenic specificities, the IgG subclasses, and the involvement of complement in this observation.We suggest that anti-GBM disease is a heterogeneous entity and that the study of IgG subclasses by immunofluorescence may help to distinguish categories with different severities.
抗肾小球基底膜(GBM)病是一种由靶向IV型胶原α3链NC1结构域的自身抗体引起的超急性增殖性肾小球肾炎。在此,我们描述了一例非典型抗GBM病病例,表现为依赖透析的急性肾衰竭,肾小球受累程度异常轻微。我们发现免疫球蛋白G(IgG)沉积仅限于不常见的IgG2和IgG4亚类,通过免疫荧光法检测血液中抗GBM抗体呈阳性,但酶联免疫吸附测定(ELISA)法检测为阴性。该患者接受了血浆置换、皮质类固醇和环磷酰胺治疗。他最终恢复了正常肾功能。该病例表明,经活检证实的抗GBM病致病性可能降低。参考先前对健康或轻症个体血液中抗GBM检测的研究,我们讨论了该观察结果中的抗原特异性、IgG亚类以及补体的参与情况。我们认为抗GBM病是一种异质性疾病,通过免疫荧光法研究IgG亚类可能有助于区分不同严重程度的类别。